Literature DB >> 12855496

Balancing benefits and harms in health care.

Luis Gabriel Cuervo, Mike Clarke.   

Abstract

Mesh：

Substances：

Year:  2003        PMID： 12855496      PMCID： PMC1126436          DOI： 10.1136/bmj.327.7406.65

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  9 in total

Review 1.  Improving the quality of reports of meta-analyses of randomised controlled trials: the QUOROM statement. Quality of Reporting of Meta-analyses.

Authors:  D Moher; D J Cook; S Eastwood; I Olkin; D Rennie; D F Stroup
Journal:  Lancet       Date:  1999-11-27       Impact factor: 79.321

2.  NSAIDS and selective COX-2 inhibitors: competition between gastroprotection and cardioprotection.

Authors:  M Boers
Journal:  Lancet       Date:  2001-04-21       Impact factor: 79.321

Review 3.  Adverse drug reactions: keeping up to date.

Authors:  Jeffrey K Aronson; Sheena Derry; Yoon K Loke
Journal:  Fundam Clin Pharmacol       Date:  2002-02       Impact factor: 2.748

Review 4.  Malignant melanoma (non-metastatic).

Authors:  David Crosby; Thomas Crosby; Malcolm Mason
Journal:  Clin Evid       Date:  2003-06

Review 5.  Squamous cell carcinoma of the skin (non-metastatic).

Authors:  Adèle Green; Robin Marks
Journal:  Clin Evid       Date:  2003-06

6.  Comparison of upper gastrointestinal toxicity of rofecoxib and naproxen in patients with rheumatoid arthritis. VIGOR Study Group.

Authors:  C Bombardier; L Laine; A Reicin; D Shapiro; R Burgos-Vargas; B Davis; R Day; M B Ferraz; C J Hawkey; M C Hochberg; T K Kvien; T J Schnitzer
Journal:  N Engl J Med       Date:  2000-11-23       Impact factor: 91.245

Review 7.  Efficacy, tolerability, and upper gastrointestinal safety of celecoxib for treatment of osteoarthritis and rheumatoid arthritis: systematic review of randomised controlled trials.

Authors:  Jonathan J Deeks; Lesley A Smith; Matthew D Bradley
Journal:  BMJ       Date:  2002-09-21

8.  The CONSORT statement: revised recommendations for improving the quality of reports of parallel group randomized trials.

Authors:  D Moher; K F Schulz; D G Altman
Journal:  BMC Med Res Methodol       Date:  2001-04-20       Impact factor: 4.615

9.  Incomplete evidence: the inadequacy of databases in tracing published adverse drug reactions in clinical trials.

Authors:  S Derry; Y K Loke; J K Aronson
Journal:  BMC Med Res Methodol       Date:  2001-09-03       Impact factor: 4.615
  9 in total
  23 in total

1.  Balancing benefits and harms in health care: observational data on harm should complement systematic reviews of benefit.

Authors:  Jan P Vandenbroucke
Journal:  BMJ       Date:  2003-09-27

2.  Balancing benefits and harms in health care: observational data on harm are already included in systematic reviews.

Authors:  Tom Jefferson; Vittorio Demicheli
Journal:  BMJ       Date:  2003-09-27

3.  How to spot bias and other potential problems in randomised controlled trials.

Authors:  S C Lewis; C P Warlow
Journal:  J Neurol Neurosurg Psychiatry       Date:  2004-02       Impact factor: 10.154

4.  Collecting and sharing information about harms.

Authors:  Munir Pirmohamed; Janet Darbyshire
Journal:  BMJ       Date:  2004-07-03

5.  Benefits and harms of drug treatments.

Authors:  Jan P Vandenbroucke
Journal:  BMJ       Date:  2004-07-03

Review 6.  Synthesising licensing data to assess drug safety.

Authors:  Klim McPherson; Elina Hemminki
Journal:  BMJ       Date:  2004-02-28

Review 7.  Tacrolimus versus ciclosporin as primary immunosuppression for kidney transplant recipients: meta-analysis and meta-regression of randomised trial data.

Authors:  Angela C Webster; Rebecca C Woodroffe; Rod S Taylor; Jeremy R Chapman; Jonathan C Craig
Journal:  BMJ       Date:  2005-09-12

8.  An assessment of the publicly disseminated evidence of safety used in decisions to withdraw medicinal products from the UK and US markets.

Authors:  Andrea Clarke; Jonathan J Deeks; Saad A W Shakir
Journal:  Drug Saf       Date:  2006       Impact factor: 5.606

9.  Sub-lingual immunotherapy: world allergy organization position paper 2009.

Authors:  G Walter Canonica; Jean Bousquet; Thomas Casale; Richard F Lockey; Carlos E Baena-Cagnani; Ruby Pawankar; Paul C Potter; Philippe J Bousquet; Linda S Cox; Stephen R Durham; Harold S Nelson; Giovanni Passalacqua; Dermot P Ryan; Jan L Brozek; Enrico Compalati; Ronald Dahl; Luis Delgado; Roy Gerth van Wijk; Richard G Gower; Dennis K Ledford; Nelson Rosario Filho; Erkka J Valovirta; Osman M Yusuf; Torsten Zuberbier
Journal:  World Allergy Organ J       Date:  2009-11-19       Impact factor: 4.084

Review 10.  Interventions for smoking cessation and reduction in individuals with schizophrenia.

Authors:  Daniel T Tsoi; Mamta Porwal; Angela C Webster
Journal:  Cochrane Database Syst Rev       Date:  2013-02-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.